共 50 条
- [11] Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR) Cardiovascular Drugs and Therapy, 2020, 34 : 357 - 370
- [12] Presence of the V122I Variant of Hereditary Transthyretin-Mediated Amyloidosis Among Self-Reported White Individuals in a Sponsored Genetic Testing Program CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2021, 14 (05): : E003466
- [16] Neurological onset in patients with V122I hereditary transthyretin amyloidosis: a glitch in the paradigm Neurological Sciences, 2023, 44 : 4569 - 4571